Assessing the clinical significance of anti-Cr^a and anti-M in a chronically transfused sickle cell patient

1. Beattie K. American Red Cross Blood Services, Southeastern Michigan Region, Detroit, MI (personal communication).Search in Google Scholar

2. Widmann FK, ed. Technical manual. 9th ed. Arlington, VA: American Association of Blood Banks, 1985:156.Search in Google Scholar

3. Ibid, 195–262.Search in Google Scholar

4. Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions. Arlington, VA: American Association of Blood Banks, 1982:91–119.Search in Google Scholar

5. Daniels GL. Blood group antigens of high frequency: a serological and genetical study (thesis). London: MRC Blood Group Unit, University College, 1980:253–65.Search in Google Scholar

6. McSwain B, Robins C. A clinically significant anti-Cr^a (letter). Transfusion 1988;28:289–90.10.1046/j.1537-2995.1988.28388219165.x3368942Search in Google Scholar

7 Smith KJ, Coonce LS, South SF, Troup GM. A nti-Cr^a: fem ily study and survival of chromium-labeled incompatible red cells in a Spanish-American patient. Transfusion 1983;23:167–9.10.1046/j.1537-2995.1983.23283172860.x6836696Search in Google Scholar

8. Ross DG, McCall L Transfusion significance of anti-Cr^a (letter). Transfusion l985;25:84.10.1046/j.1537-2995.1985.25185116515.x3918364Search in Google Scholar

9. International Committee for Standardization in Haematology Recommended method for radioisotope red-cell survival ¾, studies. Br J Hematol 1980;45:659-66.10.1111/j.1365-2141.1980.tb07189.x7426443Search in Google Scholar

10. Silvergleid AJ, Wells RF, Hafleigh EB, Korn G, KellnerJJ, Grumet FC. Compatibility testing using ⁵¹chromium labeled red blood cells in crossmatch positive patients. Transfusion 1978;18:8–14.10.1046/j.1537-2995.1978.18178118571.x625785Search in Google Scholar

11. Davey RJ, Rosen SL, Gustafson ML, Holland PV ⁵¹ Chromium red cell survival as a measure of transfusion compatibility. Blood 1979;54(supplement 1):121.Search in Google Scholar

12. Petz LD, Yam Ę Wilkinson L, Garratty G, Lubin B, Mentzer W Increased IgG molecules bound to the surface of red blood cells Of patients with sickle cell anemia. Blood 1984;64:301–4.10.1182/blood.V64.1.301.301Search in Google Scholar

13. Alperin JB, Riglin H, Branch DR, Gallagher MT, Petz LD. Anti-M causing a delayed hemolytic transfusion reaction. Transfusion 1983;23:322–4.10.1046/j.1537-2995.1983.23483276867.x6879672Search in Google Scholar

14. Nance SJ, Arndt Ę Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay Transfusion 1987;27:449–52.Search in Google Scholar